Scholar Rock Holding (SRRK) Capital Expenditures (2017 - 2026)
Scholar Rock Holding (SRRK) recorded Capital Expenditures of $1,000 in Q2 2026, down 99.5% from $215,000 a year earlier and down 98.5% from the prior quarter.
Scholar Rock Holding (SRRK) Capital Expenditures (2017 - 2026) Analysis & Trends
On a TTM basis, Scholar Rock Holding's Capital Expenditures came in at $185,000 as of Jun 30, 2026, down 65.7% year-over-year; for FY2025, it was $602,000, up 514.3% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -31.8% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $98,000 in FY2024 (+38.0%), $71,000 in FY2023 (-93.3%), $1.06 million in FY2022 (-79.7%) and $5.25 million in FY2021 (+28.4%).
- The Q2 2026 figure is the lowest quarterly Capital Expenditures in data going back to Q3 2017.
- On a year-over-year basis, Capital Expenditures rose in three of the last five quarters, with growth averaging 183.9%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 877.3% in Q2 2025, against a decline of 99.5% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $68,000 (Q1 2026), $32,000 (Q4 2025) and $84,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Scholar Rock Holding | 5.88 Bn | 5.88 Bn | - | 1,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 215,000.00 |
| Mar 31, 2025 | 271,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 117,000.00 |
| Sep 30, 2022 | 27,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | 443,000.00 |
| Dec 31, 2021 | 542,000.00 |
| Sep 30, 2021 | 1.41 Mn |
| Jun 30, 2021 | 983,000.00 |
| Mar 31, 2021 | 2.31 Mn |
Scholar Rock Holding Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SRRK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SRRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SRRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();